Abstract:Enzymes of the non-conventional yeast Yarrowia lipolytica seem to be tailor-made for the conversion of lipophilic substrates. Herein, we cloned and overexpressed the Zn-dependent alcohol dehydrogenase ADH2 from Yarrowia lipolytica in Escherichia coli. The purified enzyme was characterized in vitro. The substrate scope for YlADH2 mediated oxidation and reduction was investigated spectrophotometrically and the enzyme showed a broader substrate range than its homolog from Saccharomyces cerevisiae. A preference fo… Show more
“…In the Y. lipolytica strains, stereoselective dehydrogenases have been identified [25]. We assumed based on this statement and Ribeiro's work [2], that the reduction of 1 would therefore be catalysed by dehydrogenase.…”
Section: Resultsmentioning
confidence: 94%
“…1 H NMR (500 MHz, CD 3 OD, Figure S2): 1. 25 The configuration of the individual enantiomers of α'-1'-hydroxyethyl-γ-butyrolactone 2 was determined by comparing it to the biotransformation of 1 by the Yarrowia lipolytica strain found in literature data [18] and results of biotransformation 1 by Rhodotorula marina AM77 described in the Supplementary Materials. (Section S1 and Figure S1)…”
α’-1’-Hydroxyethyl-γ-butyrolactone—a product of reduction of α-acetylbutyrolactone possesses two stereogenic centres and two reactive functionalities (an alcohol and an ester group). Additionally, this compound has a similar structure to γ-butyrolactone (GBL) which is psychoactive. In the present work, biotransformation using seven yeast strains was used to obtain anti stereoisomers of α’-1’-hydroxyethyl-γ-butyrolactone. The process was carried out in both growing and resting culture. The effect of media composition and organic solvent addition on stereoselectivity and effectiveness of biotransformation was also studied. After one day of transformation, optically pure (3R,1’R)-hydroxylactone was obtained by means of Yarrowia lipolytica P26A in YPG medium (yeast extract (1%), peptone (2%) and glucose (2%)). In turn, the use of resting cells culture of Candida viswanathi AM120 in the presence of 10% DES (deep eutectic solvent) allowed us to obtain a (3S,1’S)-enantiomer with de = 85% (diastereomeric excess) and ee 76% (enantiomeric excess).
“…In the Y. lipolytica strains, stereoselective dehydrogenases have been identified [25]. We assumed based on this statement and Ribeiro's work [2], that the reduction of 1 would therefore be catalysed by dehydrogenase.…”
Section: Resultsmentioning
confidence: 94%
“…1 H NMR (500 MHz, CD 3 OD, Figure S2): 1. 25 The configuration of the individual enantiomers of α'-1'-hydroxyethyl-γ-butyrolactone 2 was determined by comparing it to the biotransformation of 1 by the Yarrowia lipolytica strain found in literature data [18] and results of biotransformation 1 by Rhodotorula marina AM77 described in the Supplementary Materials. (Section S1 and Figure S1)…”
α’-1’-Hydroxyethyl-γ-butyrolactone—a product of reduction of α-acetylbutyrolactone possesses two stereogenic centres and two reactive functionalities (an alcohol and an ester group). Additionally, this compound has a similar structure to γ-butyrolactone (GBL) which is psychoactive. In the present work, biotransformation using seven yeast strains was used to obtain anti stereoisomers of α’-1’-hydroxyethyl-γ-butyrolactone. The process was carried out in both growing and resting culture. The effect of media composition and organic solvent addition on stereoselectivity and effectiveness of biotransformation was also studied. After one day of transformation, optically pure (3R,1’R)-hydroxylactone was obtained by means of Yarrowia lipolytica P26A in YPG medium (yeast extract (1%), peptone (2%) and glucose (2%)). In turn, the use of resting cells culture of Candida viswanathi AM120 in the presence of 10% DES (deep eutectic solvent) allowed us to obtain a (3S,1’S)-enantiomer with de = 85% (diastereomeric excess) and ee 76% (enantiomeric excess).
We report an eco-friendly synthesis of 2-phenylethyl acetate and 2-phenylethanol from simple starting materials. The route involves a solvent-free aldol condensation reaction followed by a biocatalytic cascade.
“…Among the remaining upregulated proteins at maximized lipid yield were several known dehydrogenases, including formate dehydrogenase (FDH) and alcohol dehydrogenase (ADH). Both enzymes are well known for their role in cofactor recovery, t mainly to promote NAD(P)H-dependent enzymes that are in high demand for lipid biosynthesis [ 2 , 11 ]. Moreover, conversion of dihydroxyacetone phosphate (DHAP) to glyceraldehyde-3-phosphate (G3P) by upregulated triose phosphate isomerase could possibly enhance lipid accumulation.…”
Given the strong potential of Yarrowia lipolytica to produce lipids for use as renewable fuels and oleochemicals, it is important to gain in-depth understanding of the molecular mechanism underlying its lipid accumulation. As cellular growth rate affects biomass lipid content, we performed a comparative proteomic analysis of Y. lipolytica grown in nitrogen-limited chemostat cultures at different dilution rates. After confirming the correlation between growth rate and lipid accumulation, we were able to identify various cellular functions and biological mechanisms involved in oleaginousness. Inspection of significantly up- and downregulated proteins revealed nonintuitive processes associated with lipid accumulation in this yeast. This included proteins related to endoplasmic reticulum (ER) stress, ER–plasma membrane tether proteins, and arginase. Genetic engineering of selected targets validated that some genes indeed affected lipid accumulation. They were able to increase lipid content and were complementary to other genetic engineering strategies to optimize lipid yield.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.